In Vivo Quantification of Vcam-1 Expression in Renal Ischemia Reperfusion Injury Using Non-Invasive Magnetic Resonance Molecular Imaging

Rationale and Objective Vascular cell adhesion molecule-1 (VCAM-1) is upregulated in ischemia reperfusion injury (IRI), persisting after restoration of blood flow. We hypothesized that microparticles of iron oxide targeting VCAM-1 (VCAM-MPIO) would depict “ischemic memory” and enable in vivo assessment of VCAM-1 expression. Methodology and Findings Mice subject to unilateral, transient (30 minutes) renal ischemia and subsequent reperfusion received intravenous VCAM-MPIO (4.5 mg iron/kg body weight). Contrast agent bound rapidly (<30 minutes) in IRI-kidneys and appeared as intensely low signal areas by MRI in vivo. Automated segmentation and quantification yielded MPIO contrast volumes of 5991±354×106 µm3 in IRI vs. 87±7×106 µm3 in kidneys with no surgical intervention (P<0.001); 90±8×106 µm3 in IRI kidneys exposed to control (IgG-MPIO) and 625±80×106 µm3, in IRI kidneys pre-treated with a blocking dose of VCAM-1 antibody (P<0.001). In keeping with quantitative MRI data, VCAM-1 mRNA expression in IRI was 65-fold higher than in kidneys without surgical intervention (3.06±0.63 vs. 0.05±0.02, P<0.001). Indeed VCAM-1 mRNA expression and VCAM-MPIO contrast volume were highly correlated (R2 = 0.901, P<0.01), indicating that quantification of contrast volume reflected renal VCAM-1 transcription. Serial imaging showed VCAM-MPIO accumulation at target within 30 minutes, persisting for ≥90 minutes, while unbound VCAM-MPIO was cleared rapidly from blood, with sequestration by mac-3 positive Kupffer cells in the liver and monocyte/macrophages in the spleen. Conclusions (1) VCAM-MPIO detected VCAM-1 expression and defined its 3-dimensional distribution, revealing “ischemic memory” in renal IRI; (2) automated volumetric quantification of VCAM-MPIO accurately reflected tissue levels of VCAM-1 mRNA; and (3) VCAM-MPIO bound rapidly to target with active sequestration of unbound MPIO in the liver and spleen.

[1]  S. Neubauer,et al.  Assessment of motion gating strategies for mouse magnetic resonance at high magnetic fields , 2004, Journal of magnetic resonance imaging : JMRI.

[2]  M. Reinhardt,et al.  Ultrasound derived imaging and quantification of cell adhesion molecules in experimental autoimmune encephalomyelitis (EAE) by Sensitive Particle Acoustic Quantification (SPAQ) , 2005, NeuroImage.

[3]  L. Kappelle,et al.  Inflammatory Cell Adhesion Molecules in Ischemic Cerebrovascular Disease , 2002, Stroke.

[4]  T. Maniatis,et al.  Transcriptional regulation of endothelial cell adhesion molecules : NF-icB and cytokine-inducible enhancers , 2004 .

[5]  J. Harlan,et al.  The Role of Leukocyte and Endothelial Adhesion Molecules in Ischemia – Reperfusion Injury , 1997, Thrombosis and Haemostasis.

[6]  M. Mattson,et al.  Acute kidney injury leads to inflammation and functional changes in the brain. , 2008, Journal of the American Society of Nephrology : JASN.

[7]  Eric Tom,et al.  Myocardial Ischemic Memory Imaging With Molecular Echocardiography , 2007, Circulation.

[8]  M. Mathru.  Interleukin-6 mediates lung injury following ischemic acute kidney injury or bilateral nephrectomy , 2009 .

[9]  R. Colvin,et al.  Normal mouse kidneys contain activated and CD3+CD4−CD8− double‐negative T lymphocytes with a distinct TCR repertoire , 2008, Journal of leukocyte biology.

[10]  Ralph Weissleder,et al.  Detection of Vascular Adhesion Molecule-1 Expression Using a Novel Multimodal Nanoparticle , 2005, Circulation research.

[11]  J. Lindner,et al.  Molecular Imaging of Inflammation in Atherosclerosis With Targeted Ultrasound Detection of Vascular Cell Adhesion Molecule-1 , 2007, Circulation.

[12]  R. Atkins,et al.  Expression of VCAM-1 and E-selectin in an in vivo model of endothelial activation. , 1993, The American journal of pathology.

[13]  H. Rabb,et al.  The role of adhesion molecules and T cells in ischemic renal injury , 2003, Current opinion in nephrology and hypertension.

[14]  Aliasger K Salem,et al.  Leukocyte-inspired biodegradable particles that selectively and avidly adhere to inflamed endothelium in vitro and in vivo , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[15]  H. Rabb,et al.  IL‐1 and TNF independent pathways mediate ICAM‐1/VCAM‐1 up‐regulation in ischemia reperfusion injury , 2001, Journal of leukocyte biology.

[16]  N. Sibson,et al.  Glyconanoparticles allow pre-symptomatic in vivo imaging of brain disease , 2009, Proceedings of the National Academy of Sciences.

[17]  F. Beyersdorf.  The use of controlled reperfusion strategies in cardiac surgery to minimize ischaemia/reperfusion damage. , 2009, Cardiovascular research.

[18]  K. Leong,et al.  MR imaging of biodegradable polymeric microparticles: A potential method of monitoring local drug delivery , 2005, Magnetic resonance in medicine.

[19]  K. Ley,et al.  Protection from ischemia-reperfusion induced severe acute renal failure by blocking E-selectin , 2000, Critical care medicine.

[20]  L. Becker.  Myocardial Reperfusion Injury , 2004, Journal of Thrombosis and Thrombolysis.

[21]  R. Schuster,et al.  Ischemic and non-ischemic acute kidney injury cause hepatic damage. , 2009, Kidney international.

[22]  S. Neubauer,et al.  Magnetic Resonance Imaging of Endothelial Adhesion Molecules in Mouse Atherosclerosis Using Dual-Targeted Microparticles of Iron Oxide , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[23]  Alan P. Koretsky,et al.  In vivo labeling of adult neural progenitors for MRI with micron sized particles of iron oxide: Quantification of labeled cell phenotype , 2009, NeuroImage.

[24]  R. P. Wuthrich,et al.  REGULATION OF CYTOKINE‐STIMULATED VASCULAR CELL ADHESION MOLECULE‐1 EXPRESSION IN RENAL TUBULAR EPITHELIAL CELLS , 1993, Transplantation.

[25]  Alan P Koretsky,et al.  Sizing it up: Cellular MRI using micron‐sized iron oxide particles , 2005, Magnetic resonance in medicine.

[26]  Robin P Choudhury,et al.  Molecular imaging in atherosclerosis, thrombosis, and vascular inflammation. , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[27]  R. Colvin,et al.  Phenotypic and Functional Characterization of Kidney-Infiltrating Lymphocytes in Renal Ischemia Reperfusion Injury1 , 2006, The Journal of Immunology.

[28]  Pierre Croisille,et al.  Effect of cyclosporine on reperfusion injury in acute myocardial infarction. , 2008, The New England journal of medicine.

[29]  Jurgen E Schneider,et al.  In vivo magnetic resonance imaging of acute brain inflammation using microparticles of iron oxide , 2007, Nature Medicine.

[30]  Ralph Weissleder,et al.  18F-4V for PET-CT imaging of VCAM-1 expression in atherosclerosis. , 2009, JACC. Cardiovascular imaging.

[31]  K. Kelly.  Distant effects of experimental renal ischemia/reperfusion injury. , 2003, Journal of the American Society of Nephrology : JASN.

[32]  G. Rosen,et al.  Characterization of the promoter for vascular cell adhesion molecule-1 (VCAM-1). , 1992, The Journal of biological chemistry.

[33]  S. Neubauer,et al.  Visualization of Activated Platelets by Targeted Magnetic Resonance Imaging Utilizing Conformation-Specific Antibodies against Glycoprotein IIb/IIIa , 2008, Journal of Vascular Research.

[34]  A. Arbor,et al.  Molecular determinants of reperfusion-induced leukocyte adhesion and vascular protein leakage. , 1994, Circulation research.

[35]  E. Braunwald,et al.  Myocardial reperfusion: a double-edged sword? , 1985, The Journal of clinical investigation.

[36]  Alan P Koretsky,et al.  MRI detection of single particles for cellular imaging. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[37]  M. Goddard,et al.  Endothelial activation in the transplanted human heart from organ retrieval to 3 months after transplantation: an observational study. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[38]  G. D. del Zoppo,et al.  P‐Selectin and Intercellular Adhesion Molecule‐1 Expression After Focal Brain Ischemia and Reperfusion , 1994, Stroke.

[39]  Qing Ye,et al.  In situ labeling of immune cells with iron oxide particles: an approach to detect organ rejection by cellular MRI. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[40]  K. Ley,et al.  Blocking P‐selectin protects from ischemia/reperfusion‐induced acute renal failure , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.